<html><body><pre>
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5467 Introduced in House (IH)]

&lt;DOC&gt;






117th CONGRESS
  1st Session
                                H. R. 5467

   To amend the Federal Food, Drug, and Cosmetic Act to clarify that 
 artificial intelligence and machine learning technologies can qualify 
  as a practitioner eligible to prescribe drugs if authorized by the 
  State involved and approved, cleared, or authorized by the Food and 
              Drug Administration, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 30, 2021

Mr. Schweikert introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
   To amend the Federal Food, Drug, and Cosmetic Act to clarify that 
 artificial intelligence and machine learning technologies can qualify 
  as a practitioner eligible to prescribe drugs if authorized by the 
  State involved and approved, cleared, or authorized by the Food and 
              Drug Administration, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Healthy Technology Act of 2021''.

SEC. 2. PRESCRIPTION OF DRUGS BY ARTIFICIAL INTELLIGENCE OR MACHINE 
              LEARNING TECHNOLOGIES.

    Section 503(b) of Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
353(b)) is amended by adding at the end the following:
    ``(6) In this subsection, the term `practitioner licensed by law to 
administer such drug' includes artificial intelligence and machine 
learning technology that are--
            ``(A) authorized pursuant to a statute of the State 
        involved to prescribe the drug involved; and
            ``(B) approved, cleared, or authorized under section 
        510(k), 513, 515, or 564.''.
                                 &lt;all&gt;
</pre></body></html>
